Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura

This publication has 100 references indexed in Scilit:

• Self‐reported health‐related quality of life in adults with chronic immune thrombocytopenic purpura
  American Journal of Hematology, 2007
• Single dose of anti-D immune globulin at 75μg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children
  The Journal of Pediatrics, 2006
• Long-Term Outcome of Otherwise Healthy Individuals with Incidentally Discovered Borderline Thrombocytopenia
  PLoS Medicine, 2006
• Intravenous Immunoglobulin for Autoimmune Thrombocytopenic Purpura
  Human Immunology, 2005
• Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone
  New England Journal of Medicine, 2003
• Diagnostic Value of Tests for Reticulated Platelets, Plasma Glycocalicin, and Thrombopoietin Levels for Discriminating Between Hyperdestructive and Hypoplastic Thrombocytopenia
  American Journal of Clinical Pathology, 2001
• A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood
  The Journal of Pediatrics, 1997
• Acute immune thrombocytopenic purpura: A comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin
  The Journal of Pediatrics, 1994
• Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone Therapy
  New England Journal of Medicine, 1994
• Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma Globulin
  New England Journal of Medicine, 1982